Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × stenoparib × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

pembrolizumab 52 Carboplatin 37 Specimen Handling 34 Magnetic Resonance Spectroscopy 31 Biopsy 31 Cyclophosphamide 29 Nivolumab 25 Dexamethasone 22 fludarabine 21 Paclitaxel 19 Gemcitabine 19 Bevacizumab 19 venetoclax 18 Pemetrexed 17 Temozolomide 14 Rituximab 14 Cisplatin 14 Lenalidomide 13 atezolizumab 12 Prednisone 12 Cetuximab 12 Azacitidine 12 Fulvestrant 10 Vincristine 9 Radiotherapy 9 Irinotecan 9 fludarabine phosphate 8 durvalumab 8 carfilzomib 8 aldesleukin 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06681220 2026-03-11

Relapsed SCLC

VA Office of Research and Development

Phase 1/2 Recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡